Related Experiment Video
Updated: Dec 16, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Functionalized exosome harboring bioactive molecules for cancer therapy
Yoon Kyoung Kim1, Yoonjeong Choi1, Gi-Hoon Nam1
1KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea; Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Exosomes, tiny vesicles involved in cell communication, show promise for cancer therapy drug delivery due to their biocompatibility and targeting abilities. This review explores exosome-mediated delivery advancements and clinical use factors.
Area of Science:
- Biotechnology
- Nanomedicine
- Cancer Therapy
Background:
- Exosomes are nanosized vesicles secreted by cells, acting as crucial intercellular communication intermediates by carrying bioactive molecules.
- Their inherent properties, including biocompatibility, tumor targeting, and prolonged in vivo circulation, make them attractive for drug delivery applications.
Purpose of the Study:
- To review recent approaches and advances in exosome-mediated delivery of bioactive molecules for cancer therapy.
- To discuss factors influencing the clinical application of exosomes in cancer treatment.
Main Methods:
- Literature review of recent studies on exosome-mediated drug delivery for cancer.
- Analysis of factors affecting the clinical translation of therapeutic exosomes.
Main Results:
- Exosomes facilitate the delivery of diverse therapeutic payloads (chemicals, proteins, nucleic acids).
- Key properties like biocompatibility and tumor targeting enhance their therapeutic potential.
- Several factors impact the feasibility and efficacy of clinical exosome applications.
Conclusions:
- Exosome-mediated delivery represents a promising strategy for advancing cancer therapy.
- Further research and consideration of clinical factors are essential to fully realize the potential of therapeutic exosomes.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Mesenchymal Stem Cells

